Growth Hormone (GH) treatments in pediatric and adults with PWS have proven to improve body morphology and composition, physical performance, cognition, psychomotor development, respiratory function, and quality of life with few adverse effects [30,31,32] and could influence anthropometric measures. The gene discussed is GH1; the disease is Prader-Willi syndrome.